IVERIC bio (ISEE) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
May 4, 2022 6:32 AM EDT- Zimura® GATHER2 Topline Data Expected in the Third Quarter of this Year-
- GATHER2 Trial Completion at 94% for Year One; Patient Retention Continues to Exceed Expectations with a Target 12-Month Injection Fidelity Rate of Greater than 90%
- U.S. Patent Covering Methods of Treating GA with Zimura Granted by USPTO
- Conference Call and Webcast Today, May 4, 2022, at 8:00 a.m. ET
PARSIPPANY, N.J.--(BUSINESS... More
